EN

News and Updates

QART MEDICAL has Completed Enrollment in its Multi-Center Clinical Study

QART Medical, Raanana, Israel: QART is excited to announce the completion of patient enrollment in the Feasibility, Usability & Performance multi-center clinical study of the Q300™ system. QART anticipates having final results from this study during Q1 2023. Interim results indicate a favorable agreement between the Q300™ and “gold standard” measurements, good usability, and the great importance of using the Q300™ system, in selecting WHO2021-compliant sperm cells.

Read more

QART MEDICAL – FDA Registration

QART Medical is excited to announce a major milestone for our company: We have registered our flagship product, the Q300™ with the United States Food and Drug Administration (FDA). The Q300™ system empowers embryologists to make objective, quantitative, recorded, and highly-informed decisions about the sperm cells that they intend to select for injection into oocytes during the most prevalent IVF procedure, ICSI (intra cytoplasmic sperm injection).

Read more

QART Medical – Presentation at the JSRM 2022 Conference

QART Medical presented at the 67th Annual Meeting of the Japan Society for Reproductive Medicine, on November 3-4th, 2022 (see: http://www.jsrm.or.jp/en/meetings_sch.html).

The conference took place in the Pacifico Yokohama Conference Center, Tokyo, Japan. The QART team showcased the Q300™ system, which empowers embryologists to make objective, quantitative, recorded, and highly-informed decisions about the sperm cells they select for injection into oocytes during IVF. The QART team was joined by our partners at Chartered Investment Managers who provided excellent in-country support. QART’s groundbreaking technology and the Q300™ system, were presented to embryologists, reproductive-medicine research scientists, hospital administrators and medical device distributors.

Read more

QART Medical, a Male Fertility Company, Discloses Recent Financing

October 20th, Raanana, Israel – The round was led by Chartered Group, an SEA-based investment management fund and included Hamamatsu Photonics and angel investors.

Read more

QART-Medical receives ISO13485 certificate

QART Medical is a MedTech startup, focusing on male fertility utilizing cutting edge bio-photonics technologies, originating from a decade’s work of Prof. Natan T. Shaked’s group in Tel-Aviv University.

Read more

QART Medical Ltd. has received ethical committee approvals

QART Medical Ltd. has received ethical committee approvals to commence clinical studies in medical centres in Israel. QART Medical is an MedTech start-up, addressing the huge unmet need of male infertility.

Read more

Qart Medical Ltd. receives Seal of Excellence from EU Horizon 2020

Read more

QART Medical Ltd. has won the 3rd (monetary) prize in the 2020 from QCII

QART Medical Ltd. has won the 3rd (monetary) prize in the 2020 Qingdao High-tech Zone Lanebest International Innovation and Entrepreneurship Competition.

Read more

QART receives second grant support from the Israeli Innovation Authority

QART’s R&D efforts are focused at bringing to IVF clinics worldwide a novel system called QISITM (Quantitative Interferometric Sperm Imager) – allowing the embryologist to make highly informed decisions, when selecting individual sperm cells for injection into the (female) egg in a dish, in a procedure called ICSI (intra-cytoplasmic sperm injection).

Read more

Publications

1

M. Haifler, P. Girshovitz, G. Band, G. Dardikman, I. Madjar, and N. T. Shaked, “Interferometric phase microscopy for label-free morphological evaluation of sperm cells,” Fertility and Sterility, Vol. 104, Issue 1, pp. 43-47, 2015

2

M. Balberg, M. Levi, K. Kalinowski, I. Barnea, S. Mirsky, and N. T. Shaked, “Localized measurements of physical parameters within human sperm cells obtained with wide-field interferometry,” Journal of Biophotonics 10, 1305–1314, 2017

3

S. Mirsky, I. Barnea, and N. T. Shaked, “Label-free quantitative imaging of sperm for in-vitro fertilization using interferometric phase microscopy,” Journal of Fertilization: In Vitro, IVF – Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology, 2016

4

P. Jacob Eravuchira, S. K. Mirsky, I. Barnea, M. Levi, M. Balberg, and N. T. Shaked, “Individual sperm selection by microfluidics integrated with interferometric phase microscopy,” Methods, Vol. 136, pp. 152-159, 2018

5

P. Girshovitz and N. T. Shaked, “Doubling the field of view in off-axis low-coherence interferometric imaging,” Nature – Light: Science and Applications (Nature LSA), Vol. 3, e151, pp. 1-9, 2014

6

P. Girshovitz and N. T. Shaked, “Compact and portable low-coherence interferometer with off-axis geometry for quantitative phase microscopy and nanoscopy,” Optics Express, Vol. 21, Issue 5, pp. 5701-5714, 2013

7

N. T. Shaked, “Quantitative phase microscopy of biological samples using a portable interferometer,” Optics Letters Vol. 37, No. 11, 2016-2019, 2012

8

P. Girshovitz and N. T. Shaked, “Fast phase processing in off-axis holography using multiplexing with complex encoding and live-cell fluctuation map calculation in real-time,” Optics Express, Vol. 23, Issue 7, pp. 8773-8787, 2015

9

P. Girshovitz and N. T. Shaked, “Real-time quantitative phase reconstruction in off-axis digital holography using multiplexing,” Optics Letters, Vol. 39, No. 8, 2262-2265, 2014

10

P. Girshovitz and N. T. Shaked, “Generalized cell morphological parameters based on interferometric phase microscopy and their application to cell life cycle characterization,” Biomedical Optics Express, Vol. 3, No. 8, pp. 1757-1773, 2012